Podcasts

Sean Muldoon, MD, MPH, FCCP, SVP and chief medical officer, Hospital Division, Kindred Hospitals, identifies the major differences between long-term acute care hospitals vs traditional hospitals, and compares the varied admission lengths for...

Alison Conlin, MD, MPH, medical oncologist, Providence Cancer Institute, stresses the importance of research in breast cancer care and says the stressors and outcomes of the pandemic share similarity to those of a cancer-related outcomes.

William Rayford Gwin III, MD, medical oncologist, Seattle Cancer Care Alliance, breaks down some common challenges in treating breast cancer that make it unique compared to other types of cancer, and provides some risk reducing strategies for...

Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...

Jairam Krishnamurthy, MD, FACP, assistant professor of medicine, University of Nebraska Medical Center, reviews what it is like to navigate through breast cancer care with the whole care team—including the patient, pharmacists, other...

Victor G Vogel, MD, medical oncologist, Geisinger Health System, discusses a variety of risk reducing strategies for breast cancer, including why some are “overdue,” explains why there is a lack in the uptake of medications among patients...

Ben Isgur, health research institute leader, PwC, discusses recent news from insurers who announced they are reversing their decisions to waive telehealth copays, and provides a future outlook on how the health care landscape should change in...

Steven Feldman, MD, PhD, Wake Forest University School of Medicine, discusses the real-world effectiveness of dupilumab for the treatment of atopic dermatitis, how this data is relevant for payers, and stresses the importance of studying...

Edmund Pezalla, MD, MPH, CEO, Enlightenment Bioconsult LLC, discusses treatment options for multiple sclerosis, highlights results from the ASCLEPIOS I and II studies, and notes why this data can be useful for payers.

Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology at The George Washington University School of Medicine and Health Sciences, Washington, DC, offers insight into his real-world data study in which he and his colleagues...